{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:02:12Z","timestamp":1793916132527,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014427","name":"Dystonia Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016012","name":"Huntington's Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.parkreldis.2025.107322","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:43:28Z","timestamp":1738845808000},"page":"107322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson's disease"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-7569","authenticated-orcid":false,"given":"Joohi","family":"Jimenez-Shahed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene A.","family":"Malaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-1327","authenticated-orcid":false,"given":"Michael","family":"Soileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1467-4666","authenticated-orcid":false,"given":"Connie H.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Kandukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Teigland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavnit","family":"Kukreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hambrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert H.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2025.107322_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkin. Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41531-022-00410-y","article-title":"Incidence of Parkinson disease in North America","volume":"8","author":"Willis","year":"2022","journal-title":"NPJ Parkin. Dis."},{"issue":"13","key":"10.1016\/j.parkreldis.2025.107322_bib3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2025.107322_bib4","article-title":"Parkinson disease","author":"Hauser","year":"2020","journal-title":"Medscape. Updated"},{"issue":"100","key":"10.1016\/j.parkreldis.2025.107322_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.parkreldis.2025.107322_bib6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-023-02668-9","article-title":"Access to device-aided therapies in advanced Parkinson's disease: navigating clinician biases, patient preference, and prognostic uncertainty","volume":"130","author":"Auffret","year":"2023","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107322_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40120-022-00433-w","article-title":"Comparative effectiveness of carbidopa\/levodopa enteral suspension and deep brain stimulation on pill burden reduction in medicare fee-for-service patients with advanced Parkinson's disease","volume":"12","author":"Soileau","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.parkreldis.2025.107322_bib8","unstructured":"Surgical Options: A Treatment Guide to Parkinson's Disease. Parkinson\u2019s Foundation. https:\/\/www.parkinson.org\/library\/books\/surgical-options. Accessed September 19, 2024."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107322_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1474-4422(13)70293-X","article-title":"Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson\u2019s disease: a randomised, controlled, double-blind, double-dummy study","volume":"13","author":"Olanow","year":"2014","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107322_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.26123","article-title":"Levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease: final 12-month, open-label results","volume":"30","author":"Fernandez","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JPD-140456","article-title":"Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson\u2019s disease patients","volume":"5","author":"Slevin","year":"2015","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.52177","article-title":"Neurostimulation for advanced Parkinson disease and quality of life at 5 Years: a nonrandomized controlled trial","volume":"7","author":"Jost","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107322_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaneurol.2013.5798","article-title":"Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use","volume":"71","author":"Chan","year":"2014","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.107322_bib14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40263-022-00963-9","article-title":"Comparative effectiveness of device-aided therapies on quality of life and off-time in advanced Parkinson's disease: a systematic review and bayesian network meta-analysis","volume":"36","author":"Antonini","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.parkreldis.2025.107322_bib15","article-title":"Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: associations with claims-based indicators of disease severity","volume":"3","author":"Dahodwala","year":"2020","journal-title":"Clin. Park Relat. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.107322_bib16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/03007995.2018.1502165","article-title":"Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach","volume":"34","author":"Antonini","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.parkreldis.2025.107322_bib17","article-title":"Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: revelations from the MANAGE-PD validation cohort","volume":"116","author":"Fernandez","year":"2023","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12883-022-02560-1","article-title":"Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries","volume":"22","author":"Malaty","year":"2022","journal-title":"BMC Neurol."},{"key":"10.1016\/j.parkreldis.2025.107322_bib19","article-title":"Timely referral for device-aided therapy in Parkinson's disease. Development of a screening tool","volume":"109","author":"Moes","year":"2023","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41531-023-00523-y","article-title":"Care access and utilization among medicare beneficiaries living with Parkinson's disease","volume":"9","author":"Pearson","year":"2023","journal-title":"NPJ Parkin. Dis."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107322_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1212\/WNL.0000000000000017","article-title":"Disparities in deep brain stimulation surgery among insured elders with Parkinson disease","volume":"82","author":"Willis","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107322_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000275491","article-title":"Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries","volume":"34","author":"Wright Willis","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.28265","article-title":"Burden of Parkinson's disease by severity: health care costs in the U.S. Medicare population","volume":"36","author":"Dahodwala","year":"2021","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-023-00410-1","article-title":"Economic burden of Parkinson's disease: a multinational, real-world, cost-of-illness study","volume":"11","author":"Chaudhuri","year":"2024","journal-title":"Drugs Real World Outcomes"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12883-019-1276-8","article-title":"Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients","volume":"19","author":"Fasano","year":"2019","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12883-022-02554-z","article-title":"Criteria for identification of advanced Parkinson's disease: the results of the Italian subgroup of OBSERVE-PD observational study","volume":"22","author":"Stefani","year":"2022","journal-title":"BMC Neurol."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107322_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00702-019-02034-8","article-title":"Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation","volume":"126","author":"Richter","year":"2019","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2025.107322_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42466-022-00176-x","article-title":"Characterization of advanced Parkinson's disease in Germany: results of the non-interventional OBSERVE-PD study","volume":"4","author":"Pedrosa","year":"2022","journal-title":"Neurol. Res. Pract"},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107322_bib29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mdc3.12988","article-title":"Access and use of device-aided therapies for Parkinson's disease in Denmark","volume":"7","author":"Henriksen","year":"2020","journal-title":"Mov Disord Clin Pract"},{"issue":"9","key":"10.1016\/j.parkreldis.2025.107322_bib30","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4045\/tidsskr.16.0711","article-title":"Use of advanced therapies for Parkinson's disease in Norway","volume":"137","author":"Ezat","year":"2017","journal-title":"Tidsskr. Nor. Laegeforen"},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107322_bib31","article-title":"Patient perceptions and knowledge of Parkinson's disease and treatment (KnowPD)","author":"Salinas","year":"2020","journal-title":"Clin. Park Relat. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2025.107322_bib32","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00702-023-02693-8","article-title":"Current and novel infusion therapies for patients with Parkinson's disease","volume":"130","author":"Antonini","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2025.107322_bib36","unstructured":"Parkinson\u2019s Foundation. Hispanic and Latino Community & Parkinson's. https:\/\/www.parkinson.org\/living-with-parkinsons\/finding-care\/hispanic-latino-community."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107322_bib37","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/gerona\/glad016","article-title":"Ethnicity and Parkinson\u2019s disease: motor and nonmotor features and disease progression in latino patients living in rural California","volume":"78","author":"Folle Duarte","year":"2023","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107322_bib38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JPD-212735","article-title":"Barriers to accessing healthcare services for people with Parkinson's disease: a scoping review","volume":"11","author":"Zaman","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2025.107322_bib39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/brainsci13050736","article-title":"Device-aided therapies in Parkinson's disease-results from the German Care4PD study","volume":"13","author":"Fr\u00fcndt","year":"2023","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107322_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/13696998.2019.1693383","article-title":"The effect of functional status impairment on nursing home admission risk among patients with advanced Parkinson's disease","volume":"23","author":"Shih","year":"2020","journal-title":"J. Med. Econ."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107322_bib41","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200138","article-title":"Racial and ethnic disparities in Parkinson disease: a Call to action","volume":"13","author":"Aamodt","year":"2023","journal-title":"Neurol Clin Pract"},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107322_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12912-024-01931-y","article-title":"The role of nurses for patients with Parkinson's disease at home: a scoping review","volume":"23","author":"Fujita","year":"2024","journal-title":"BMC Nurs."},{"issue":"12","key":"10.1016\/j.parkreldis.2025.107322_bib43","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/brainsci12121735","article-title":"Telemedicine in the management of Parkinson's disease: achievements, challenges, and future perspectives","volume":"12","author":"Cubo","year":"2022","journal-title":"Brain Sci."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500063X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500063X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:04:52Z","timestamp":1768935892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202500063X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S135380202500063X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107322","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of patient characteristics, social drivers of health, and geographic location on access to device-aided therapies among medicare beneficiaries with advanced Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107322"}}